[HTA Rapid report-Scemblix (chronic myeloid leukaemia - CML)]
Center for Drug Evaluation
Record ID 32018014672
Chinese (Mandarin)
Details
Project Status:
Completed
Year Published:
2025
URL for published report:
https://www.nhi.gov.tw/ch/dl-85859-fe4cabdc52f7469e9d8fe7b8c41cff8b-1.pdf
English language abstract:
There is no English language summary available
Publication Type:
Not Assigned
MeSH Terms
- Leukemia, Myeloid
- Leukemia, Myeloid, Chronic-Phase
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Antineoplastic Agents
- Tyrosine Kinase Inhibitors
Contact
Organisation Name:
Center for Drug Evaluation
Contact Address:
3F.,No.465, Sec.6, Zhongxiao E. Rd., Taipei 11557, Taiwan. R.O.C.
Contact Name:
Li Ying (Grace) Huang
Contact Email:
lyhuang277@cde.org.tw
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.